SUBSCRIBE
SUBSCRIBE
News   Policy

Eli Lilly and Company Says Judge Prevents Launch of Generic Evista

April 23, 2009 | 
1 min read

LOS ANGELES, April 22 (Reuters) - Eli Lilly and Co (LLY.N) said on Wednesday that a federal judge issued a preliminary injunction preventing the launch of a generic version of osteoporosis drug Evista.

Legal
Eli Lilly and Company
MORE ON THIS TOPIC
A handshake of businessmen. Modern design with a positive context. Concept of help, support, and agreement between businessmen. Modern art collage, trendy magazine style.
Mergers & acquisitions
Novo, Catalent $16.5B Deal Wins EU Blessing as US Antitrust Scrutiny Mounts
December 9, 2024
 · 
2 min read
 · 
Tristan Manalac
Pictured: AstraZeneca building in Gothenburg/iStoc
China
AstraZeneca Names New International Operations Lead Amid Probe on China Exec
December 5, 2024
 · 
3 min read
 · 
Tristan Manalac
Pictured: A scientist works behind an FDA sign/Tay
FDA Tracker
AstraZeneca, Merus Notch Cancer Approvals
December 5, 2024
 · 
212 min read
 · 
BioSpace Editorial Staff
Novartis' office building in Marburg, Germany
Legal
Novartis Loses Appeal to Bar Entresto Generic From U.S. Market
December 5, 2024
 · 
2 min read
 · 
Tristan Manalac